NASDAQ:EFTR

Effector Therapeutics Stock Earnings Reports

etoro logo Buy EFTR
*Your capital is at risk
$0.0006
+0 (+0%)
At Close: Jun 03, 2026

eFFECTOR Therapeutics Earnings Calls

Mar 31, 2026 (Upcoming)
Release date Aug 12, 2026
EPS estimate -$6.40
EPS actual -
Revenue estimate 100K
Revenue actual -
Expected change +/- 23.90%
Dec 31, 2025
Release date Mar 24, 2026
EPS estimate -$6.40
EPS actual -
Revenue estimate -
Revenue actual -
Oct 01, 2025
Release date Oct 27, 2025
EPS estimate -
EPS actual -
Revenue estimate -
Revenue actual -
Jul 01, 2025
Release date Aug 07, 2025
EPS estimate -
EPS actual -
Revenue estimate -
Revenue actual -

Last 4 Quarters for eFFECTOR Therapeutics

Below you can see how EFTR performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Jul 01, 2025
Release date Aug 07, 2025
Price on release $0.0002
EPS estimate -
EPS actual -
Date Price
Aug 01, 2025 $0.0002
Aug 04, 2025 $0.0002
Aug 05, 2025 $0.0002
Aug 06, 2025 $0.0002
Aug 07, 2025 $0.0002
Aug 08, 2025 $0.0002
Aug 11, 2025 $0.0002
Aug 12, 2025 $0.0002
Aug 13, 2025 $0.0002
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%
Oct 01, 2025
Release date Oct 27, 2025
Price on release $0.0002
EPS estimate -
EPS actual -
Date Price
Oct 21, 2025 $0.0002
Oct 22, 2025 $0.0002
Oct 23, 2025 $0.0002
Oct 24, 2025 $0.0002
Oct 27, 2025 $0.0002
Oct 28, 2025 $0.0002
Oct 29, 2025 $0.0002
Oct 30, 2025 $1.50
Oct 31, 2025 $0.0002
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%
Dec 31, 2025
Release date Mar 24, 2026
Price on release $0.0002
EPS estimate -$6.40
EPS actual -
Date Price
Mar 18, 2026 $0.0002
Mar 19, 2026 $0.0002
Mar 20, 2026 $0.0002
Mar 23, 2026 $0.0002
Mar 24, 2026 $0.0002
Mar 25, 2026 $0.0002
Mar 26, 2026 $0.0002
Mar 27, 2026 $0.0002
Mar 30, 2026 $0.0002
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%
Mar 31, 2026 (Upcoming)
Release date Aug 12, 2026
Price on release -
EPS estimate -$6.40
EPS actual -
Date Price
May 28, 2026 $0.0006
May 29, 2026 $0.0006
Jun 01, 2026 $0.0006
Jun 02, 2026 $0.0006
Jun 03, 2026 $0.0006

eFFECTOR Therapeutics Earnings History

Earnings Calendar

FAQ

When is the earnings report for EFTR?
eFFECTOR Therapeutics, Inc. (EFTR) has scheduled its earnings report for Aug 12, 2026 after the markets close.

What is the EFTR price-to-earnings (P/E) ratio?
EFTR P/E ratio as of Jun 03, 2026 (TTM) is -0.00003664160174.

What is the EFTR EPS forecast?
The forecasted EPS (Earnings Per Share) for eFFECTOR Therapeutics, Inc. (EFTR) for the first fiscal quarter 2026 is -$6.40.

What are eFFECTOR Therapeutics, Inc.'s retained earnings?
On its balance sheet, eFFECTOR Therapeutics, Inc. reported retained earnings of $0 for the latest quarter ending Dec 31, 2025.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT EFFECTOR THERAPEUTICS, INC.
eFFECTOR Therapeutics
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit euk...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE